387510622 | lvsmh | 15861687 | | 5394984 | 9/16/2006 12:00:00 am | transaminitis , cbd dilitation , pancreatic duct dilitation s/p stenting , s/p sphinterectomy | | dis | admission date: 3/30/2006 report status:discharge date: 2/2/2006 final discharge orders fleitman , bennett v 373-63-33-4v10 room: te tarage a cam seymasa , indiana 06498service: meddischarge patient on: 1/18/06 at 02:00 pmcontingent upon not applicablewill d/c order be used as the d/c summary: yesattending: cafaro , adalberto e. , m.d.code status:full codedisposition: rehabilitationdischarge medications:enteric coated aspirin ( baby ) ( aspirin enteri... )162 mg po dailylipitor ( atorvastatin ) 10 mg po dailyalert overridden: override added on 1/18/06 by :potentially serious interaction: niacin , vit. b-3 &atorvastatin calcium reason for override: md awarecalcium carbonate ( 500 mg elemental ca++ ) 500 mg po tidnexium ( esomeprazole ) 20 mg po dailyhydrochlorothiazide 25 mg po dailyinsulin 70/30 human 20 units sc qamavapro ( irbesartan ) 150 mg po dailyalert overridden: override added on 7/6/06 by :potentially serious interaction: potassium chloride &irbesartanpotentially serious interaction: potassium chloride &irbesartan reason for override: md previous alert overriddenoverride added on 7/6/06 by :potentially serious interaction: potassium chloride &irbesartanpotentially serious interaction: potassium chloride &irbesartan reason for override: awareprevious alert overriddenoverride added on 10/30/06 by ence , ty r. , m.d.potentially serious interaction: potassium chloride &irbesartanpotentially serious interaction: potassium chloride &irbesartan reason for override: awareprevious override reason:override added on 10/30/06 by elwonger , johnny t. , m.d.on order for potassium chloride immed. rel. po ( ref #665886938 )potentially serious interaction: irbesartan & potassiumchloride reason for override: md awareprevious override information:override added on 10/30/06 by rubiano , numbers d. , m.d.on order for potassium chloride iv ( ref # 765178698 )potentially serious interaction: irbesartan & potassiumchloride reason for override: md awarelevaquin ( levofloxacin ) 500 mg po q48hfood/drug interaction instructionadminister iron products a minimum of 2 hours before orafter a levofloxacin or ciprofloxacin dose doseif on tube feeds , please cycle ( hold 1 hr before to 2 hrafter ) take 2 hours before or 2 hours after dairy products.lopressor ( metoprolol tartrate ) 50 mg po tidstarting today ( 10/24 ) hold if: hr<55 or sbp<110food/drug interaction instructiontake consistently with meals or on empty stomach.pilocarpine 0.5% 2 drop os qid starting today ( 10/24 )multivitamin therapeutic ( therapeutic multivi... )1 tab po dailyvitamin e ( tocopherol-dl-alpha ) 400 units po dailyalphagan ( brimonidine tartrate ) 1 drop ou bidxalatan ( latanoprost ) 1 drop ou qpmdiet: house / low chol/low sat. fatactivity: walking as toleratedfollow up appointment( s ):pcp as scheduled on 4/11 1:30 ,stent removal dr menietto 7/20 1:30 endoscopy ,gi dr scroggin 8/10 9am ,allergy: nkaadmit diagnosis:abdominal painprincipal discharge diagnosis ;responsible after study for causing admission )transaminitis , cbd dilitation , pancreatic duct dilitation s/p stenting , s/p sphinterectomyother diagnosis;conditions , infections , complications , affecting treatment/staydm , htn , esophageal ca , glaucoma , ppmoperations and procedures:other treatments/procedures ( not in o.r. )s/p ercp stenting and sphinterotomy on 9/17/06brief resume of hospital course:cc: abd pain / gnr bacteremiahpi: 88f w dm , htn , s/p ppm , h/o esoph ca s/p resxn p/w acute onsetdiffuse abd pain , somewhat stronger in llq , sharp , a/w nausea. painworse with eating. had loose bms x 3-4 days , no fevers , some chills.no cp , no palps , chronic stable doe. in ed , abdct , u/s , hida scan all unremarkble , but 2/4 bcx with gnrs , and wasgiven levo/flagyl.pmh: dm , htn , tia/cva , s/p esoph ca s/p resection , s/pppmall: nkdahome meds: lipitor 10 , vit e 400 , pilocarpine , timolol , insulin 70/3020 qam , hctz 25 , ppi , lopressor 50 bid , avapro ,asapex: t96.9 p56 140/46 sats ok on ra. nad. lungs clear , rrr s1/s2.abd s/nd. very mild tenderness , somewhat localized over llq.hyperactive bs. ext wwp. nontoxiclooking.studies: abd ct: gb wall thickening , dilatation ofpancreatic duct. hida: neg for cbddist ruq u/s: gbsludgenotable labs: ast 1425 , alt 1259 , alkphos 198 , tb 1.9 , amy 90.chem 7 / cbc unremarkable. no anion gap. bcx with 2/4gnrs.a/p: 88f w abd pain of unclear etiology on admission with transaminitis ,abd pain and suspected bile duct stones and sludge. underwent ercp whichdemonstrated dilated main pancreatitic duct s/p stenting , dilated cbdwith sludge s/p sphinterectomy. transaminitis and abd pain have continuedto improve.id: given gnr bacteremia , emperically covered with levo / ceftaz.cx grew pansensitive kleb , and coverage was narrowed to levoto complete a 14 day course. surveillance cx negative.gi: marked transaminitis. norecent new meds. hepatitis serologies negative , u/s w doppler tor/o budd-chiari esp given acute onset negative , lactate + guaiac for? mesenteric ischemia( but no gap )negative. no indication for surgery.gi consulted recommended erc , results as above. lfts trendingdown s/p sphinterotomy and ercp. will f/u with gi in 2 weeks for repeatercp at oedmc .cv: cont lipitor , hctz , lopressor , avapro , asa. nosigns of ischemia , failure. uptitrated avapro givenpersistent htn , appears to be near maximally bb in terms of heartrateophth: cont eye dropsendo: h/o dm , cont insulin + scale.fen: npo pending ercp , adv to clears s/p procedure well tolerated , k/mgscales.ppx: nexium / lovenoxfull codeadditional comments:discharge condition: stableto do/plan:f/u with pcp and gi as scheduledreturn to ed with worsening symptoms of abd pain or if unable to tolerano dictated summaryentered by: saleh , zack d. , m.d. ( nm201 ) 1/18/06 @ 02 end of discharge orders 